A Study to Evaluate the Effects of E2609 on QTc Interval in Healthy Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
This thorough QT (TQT) study will take place in healthy subjects administered single doses of study drug. It will be a randomized, double-blind, placebo and active-controlled, 4-treatment crossover study. Subjects will be randomized in an equal ratio to one of 12 possible treatment sequences. Each treatment sequence will comprise all 4 treatments.
Epistemonikos ID: 47719c316306a2df6b85dd10764bef58aa04314e
First added on: May 12, 2024